Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Speaker's Bureau: Novo-Nordisk, AstraZeneca Honorarium (Speaker) Funding None References Once Weekly Dulaglutide and Major Cardiovascular EventsResults of the REWIND Trial (Researching CV Events with a Weekly INcretin in Diabetes)
2001 Jul 15;61(14):5378-81
This treatment is contraindicated if you have a personal or family history of medullary thyroid cancer, MEN 2, severe kidney disease, are pregnant or planning pregnancy, or have severe diabetic retinopathy
Provide written instructions summarising the plan
US$ 28.05
US$ 29.31
US$ 29.81
US$ 24.59
US$ 29.97
US$ 21.53
